What is the official website of Eurofins BioPharma Product Testing India ?

The official website of Eurofins BioPharma Product Testing India is https://www.advinus.com/services/gmp-analytical-testing/.

What is Eurofins BioPharma Product Testing India 's cybersecurity risk score?

Eurofins BioPharma Product Testing India has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Eurofins BioPharma Product Testing India experienced?

According to Rankiteo, Eurofins BioPharma Product Testing India currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Eurofins BioPharma Product Testing India been affected by any supply chain cyber incidents ?

According to Rankiteo, Eurofins BioPharma Product Testing India has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Eurofins BioPharma Product Testing India have SOC 2 Type 1 certification ?

According to Rankiteo, Eurofins BioPharma Product Testing India is not certified under SOC 2 Type 1.

Does Eurofins BioPharma Product Testing India have SOC 2 Type 2 certification ?

According to Rankiteo, Eurofins BioPharma Product Testing India does not hold a SOC 2 Type 2 certification.

Does Eurofins BioPharma Product Testing India comply with GDPR ?

According to Rankiteo, Eurofins BioPharma Product Testing India is not listed as GDPR compliant.

Does Eurofins BioPharma Product Testing India have PCI DSS certification ?

According to Rankiteo, Eurofins BioPharma Product Testing India does not currently maintain PCI DSS compliance.

Does Eurofins BioPharma Product Testing India comply with HIPAA ?

According to Rankiteo, Eurofins BioPharma Product Testing India is not compliant with HIPAA regulations.

Does Eurofins BioPharma Product Testing India have ISO 27001 certification ?

According to Rankiteo,Eurofins BioPharma Product Testing India is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Eurofins BioPharma Product Testing India operate in ?

Eurofins BioPharma Product Testing India operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Eurofins BioPharma Product Testing India have ?

Eurofins BioPharma Product Testing India employs approximately 0 people worldwide.

Does Eurofins BioPharma Product Testing India own any subsidiaries ?

Eurofins BioPharma Product Testing India presently has no subsidiaries across any sectors.

How many LinkedIn followers does Eurofins BioPharma Product Testing India have ?

Eurofins BioPharma Product Testing India 's official LinkedIn profile has approximately 2,534 followers.

What is the NAICS classification code for Eurofins BioPharma Product Testing India ?

Eurofins BioPharma Product Testing India is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Eurofins BioPharma Product Testing India have a Crunchbase profile ?

No, Eurofins BioPharma Product Testing India does not have a profile on Crunchbase.

Does Eurofins BioPharma Product Testing India have a LinkedIn profile ?

Yes, Eurofins BioPharma Product Testing India maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/eurofins-biopharma-product-testing-india.

How many cybersecurity incidents has Eurofins BioPharma Product Testing India experienced ?

As of August 26, 2026, Rankiteo reports that Eurofins BioPharma Product Testing India has not experienced any cybersecurity incidents.

How many peer or competitor companies does Eurofins BioPharma Product Testing India have ?

Eurofins BioPharma Product Testing India has an estimated 5,737 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

EBPTI

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Eurofins BioPharma Product Testing India Vendor Cyber Rating & Cyber Score

advinus.com

Add Your Compliance Badge

Eurofins Biopharma Product Testing India Pvt Ltd, a US FDA inspected lab with NAI (“ZERO” 483) offers GMP testing of drug substance, drug products, intermediates, starting materials and raw materials for Pharmaceutical, Chemical and Food Industries. The state-of-the-art testing facility is located in Bangalore, India. All instruments in the laboratory are 21 CFR Part 11 compliant.

EBPTI A.I CyberSecurity Scoring

Scoring History

EBPTI

Eurofins BioPharma Product Testing India CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

EBPTI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for EBPTI

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incident Types EBPTI vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incident History - EBPTI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Eurofins BioPharma Product Testing India Subsidiaries

EBPTI

Pharmaceutical Manufacturing

Website: https://www.advinus.com/services/gmp-analytical-testing/

Company Size: 0

EurofinsBiotechnology Research

Eurofins Lancaster LaboratoriesBiotechnology Research

Eurofins PSS Insourcing SolutionsBiotechnology Research

Eurofins BioPharma Product Testing ItalyPharmaceutical Manufacturing

Eurofins IT Delivery CenterIT Services and IT Consulting

Eurofins Agroscience ServicesResearch

Eurofins Agroscience Biological SolutionsResearch

Eurofins Agroscience Seed ServicesResearch Services

Eurofins Agroscience Regulatory ConsultancyResearch Services

Eurofins Agroscience Biological AssessmentResearch Services

Eurofins Agroscience Consumer/Human SafetyResearch Services

Eurofins Agroscience Environmental SafetyResearch

Eurofins Agroscience Product ChemistryResearch Services

Eurofins do Brasil Análises de Alimentos e AmbientaisResearch Services

Eurofins Environment Testing (USA)Environmental Services

Eurofins GenomicsBiotechnology Research

Eurofins Food AssuranceProfessional Services

Eurofins BiomnisMedical and Diagnostic Laboratories

Eurofins Environment Testing FranceBiotechnology

Eurofins | Solutions DurablesServices de conseil en environnement

Eurofins Hygiène HospitalièreRecherche en biotechnologie

Eurofins Biopharma Product Testing (France)Pharmaceutical Manufacturing

Eurofins Analyses Alimentaires FranceBiotechnology Research

Eurofins Central LaboratoryBiotechnology Research

Eurofins DiscoveryBiotechnology

Eurofins CDMOPharmaceutical Manufacturing

Eurofins CDMO AlphoraPharmaceutical Manufacturing

Eurofins US Food, Feed, & Supplement TestingBiotechnology Research

Eurofins Danmark - LaboratoriumBiotechnology Research

Eurofins Product Testing Denmark A/SSecurity and Investigations

Eurofins Steins LaboratoriumBiotechnology Research

Eurofins Clinical DiagnosticsBiotechnology

Eurofins Clinical Trial SolutionsBiotechnology Research

Eurofins Food, Feed & Water BeneluxBiotechnology Research

Eurofins ChileFood and Beverage Services

Eurofins Agro & HortiResearch Services

Eurofins DiscoverXBiotechnology Research

Eurofins Genomics AmericasBiotechnology

Eurofins CanadaBiotechnology Research

Eurofins Environment BeneluxEnvironmental Services

DiatherixBiotechnology Research

Eurofins ViracorMedical and Diagnostic Laboratories

ExPeCT™ anti-CD19 (FMC63) CAR TMedical and Diagnostic Laboratories

Eurofins Viracor CMV TestingBiotechnology Research

TTViWATCH™ - Torque Teno Virus qPCRMedical and Diagnostic Laboratories

Eurofins AdvinusResearch Services

Eurofins Discovery Services IndiaResearch

Eurofins CDMO IndiaResearch Services

Eurofins Bioanalytical Services IndiaResearch Services

Eurofins Advinus Agrosciences IndiaResearch Services

Loading…

Eurofins BioPharma Product Testing India Similar Companies

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Loading…

NEWS

Eurofins BioPharma Product Testing India CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-80138

SUMMARY

ClipBucket V5's web installer fails to properly validate or escape the php_cli_filepath parameter before passing it to shell execution. Unauthenticated attackers can submit a crafted POST request to the installer with a malicious php_cli_filepath value to execute arbitrary commands as the web server user.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-79912

SUMMARY

A vulnerability was detected in TOTOLINK N600R 4.3.0cu.7647_B20210106. The impacted element is the function getCurrentTime of the file /cgi-bin/cstecgi.cgi. Performing a manipulation of the argument ntp_server results in command injection. The attack can be initiated remotely. The exploit is now public and may be used.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 8.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 8.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:L/SI:L/SA:L/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.7

Exploitability

3.9

REFERENCES

CVE-2026-79911

SUMMARY

A security vulnerability has been detected in TOTOLINK N600R 4.3.0cu.7647_B20210106. The affected element is the function setSystemConfig of the file /cgi-bin/cstecgi.cgi of the component CGI Handler. Such manipulation of the argument Hostname leads to stack-based buffer overflow. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-70665

SUMMARY

Doorkeeper OpenID Connect implements an OpenID Connect authentication provider for Rails applications on top of Doorkeeper. Prior to 1.10.4, the Dynamic Client Registration (DCR) endpoint persists client-supplied scopes without validating them against the server's configured scope set. Under certain conditions, this allows a self-registered client to obtain scopes beyond what the server intended to grant. In DynamicClientRegistrationController#application_params, the scopes attribute is assigned directly from params[:scope] with no validation against Doorkeeper.configuration.scopes or optional_scopes. Combined with enforce_configured_scopes being off by default and Doorkeeper's ScopeChecker prioritizing application-level scopes over server-level scopes, this creates a privilege escalation path. This issue is fixed in version 1.10.4.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 4.2)

cvss3

Base Score: 4.2

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

1.6

REFERENCES

CVE-2026-55805

SUMMARY

Improper Neutralization of Input During Web Page Generation ("Cross-site Scripting") vulnerability in Drupal Drupal core allows Stored XSS. This issue affects Drupal core versions: from 0.0.0 to 10.6.13, from 11.3.0 to 11.3.14, from 11.4.0 to 11.4.4, from 0.0.0 to 11.0.*, from 0.0.0 to 11.1.*, from 0.0.0 to 11.2.*.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://www.drupal.org/sa-core-2026-012

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…